Potential Histologic and Molecular Predictors of Response to Temsirolimus in Patients with Advanced Renal Cell Carcinoma
- 1 September 2007
- journal article
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 5 (6), 379-385
- https://doi.org/10.3816/cgc.2007.n.020
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancerNature Medicine, 2005
- Histologic Predictors of Renal Cell Carcinoma Response to Interleukin-2-Based TherapyJournal of Immunotherapy, 2005
- Carbonic Anhydrase IX Expression Predicts Outcome of Interleukin 2 Therapy for Renal CancerClinical Cancer Research, 2005
- USING TUMOR MARKERS TO PREDICT THE SURVIVAL OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMAJournal of Urology, 2005
- TSC2 regulates VEGF through mTOR-dependent and -independent pathwaysCancer Cell, 2003
- Regulation of Hypoxia-Inducible Factor 1α Expression and Function by the Mammalian Target of RapamycinMolecular and Cellular Biology, 2002
- Intragenic PTEN/MMAC1 Loss of Heterozygosity in Conventional (Clear-Cell) Renal Cell Carcinoma is Associated with Poor Patient PrognosisLaboratory Investigation, 2002
- Loss of tumor suppressor protein PTEN during renal carcinogenesisInternational Journal of Cancer, 2002
- The rapamycin-sensitive signal transduction pathway as a target for cancer therapyOncogene, 2000
- Expression of MaTu‐MN protein in human tumor cultures and in clinical specimensInternational Journal of Cancer, 1993